InsiderTrades

Form 4 for CADL Candel Therapeutics, Inc.

Accepted 2024-11-01 00:00:00 ET · period of report 2024-10-30 · accession 0001873919-24-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-11-01 2024-10-30+ CADL Aguilar Laura K. 10% D - Sale to Iss $5.31 -21.0K 903.5K -2% -$111.6K
MI 2024-11-01 2024-10-30+ CADL Aguilar Laura K. 10% D - Sale to Iss $5.31 -21.0K 853.9K -2% -$111.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common CADL 2024-11-01 D D 7,500 $5.27 896,012 D — —
2 Common CADL 2024-10-30 D D 6,000 $5.38 911,012 D By LKA 2022 Revocable Trust — — (F1) Adjusted by 28,480 shares acquired by Dr. Aguilar-Cordova through option exercise as previously filed on 09/23/2024 (F2) Shares of common stock held by spouse LKA 2022 Revocable trust
3 Common CADL 2024-10-31 D D 7,500 $5.30 903,512 D By LKA 2022 Revocable Trust — — (F2) Shares of common stock held by spouse LKA 2022 Revocable trust
4 Common CADL 2024-10-30 D D 6,000 $5.38 868,943 I By LKA 2022 Revocable Trust — — (F2) Shares of common stock held by spouse LKA 2022 Revocable trust
5 Common CADL 2024-10-31 D D 7,500 $5.30 861,443 I — —
6 Common CADL 2024-11-01 D D 7,500 $5.27 853,943 I — —